iSERA Lifesciences Defers Board Meeting Scheduled for April 20, 2026, Over Preferential Issue
iSERA Lifesciences Limited, formerly known as Covid Technologies Limited, has announced the deferment of its Board Meeting originally scheduled for Monday, April 20, 2026.The company confirmed that the postponement of the meeting is due to the requirement of additional time needed to finalize certain procedural and documentation-related formalities connected with a proposed preferential issue.
The Board Meeting was initially scheduled to consider and approve the preferential issue of equity shares of the company on a private placement basis, in addition to reviewing other key business matters. iSERA Lifesciences Limited had previously intimated about the meeting on April 15, 2026.
Stock Price Movement
After closing on Monday, Covidh Technologies Ltd shares settled at ₹69.90, marking a robust 2.00% gain for the equity. The stock traded completely flat throughout the entire session, remaining locked at the ₹69.90 price point.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.